
| |  | |  |
Articles
|
| Expression Profiling of Estrogenic Compounds Using a Sheepshead Minnow cDNA Macroarray Patrick Larkin,1,3 Leroy C. Folmar,2 Michael
J. Hemmer,2 Arianna J. Poston,1 and Nancy D. Denslow1 1Department of Biochemistry and Molecular Biology and Center
for Biotechnology, University of Florida, Gainesville, Florida, USA;
2National Health and Environmental Effects Research Laboratory,
Gulf Ecological Division, U.S. Environmental Protection Agency, Gulf
Breeze, Florida, USA; 3EcoArray LLC, Alachua, Florida, USA Abstract A variety of anthropogenic compounds are capable of binding to the estrogen receptor (ER) of vertebrate species. Binding of these chemicals to the ER can interfere with homeostasis by altering normal gene expression patterns. The purpose of this study was to characterize the expression of 30 genes using a sheepshead minnow (Cyprinodon variegatus) cDNA macroarray. Many of the genes on the array were previously identified by differential display reverse transcriptase-polymerase chain reaction to be upregulated or downregulated in sheepshead minnows treated through aqueous exposure to known or suspected estrogenic chemicals. The results of this study show that 17ß-estradiol (E2) , 17 -ethinyl estradiol (EE2) , diethylstilbestrol (DES) , and methoxychlor (MXC) have similar genetic signatures for the 30 genes examined. The genetic signature of fish treated with p-nonylphenol was identical in pattern to that in fish treated with E2, EE2, DES, and MXC except for the additional upregulation of a cDNA clone that shares similarity to ubiquitin-conjugating enzyme 9. Endosulfan produced results that resembled the gene expression patterns of untreated control fish with exception of the upregulation of estrogen receptor and the downregulation of a cDNA clone that shares similarity to 3-hydroxy-3-methylglutaryl-coenzyme A reductase. We show that our estrogen-responsive cDNA macroarray can detect dose-dependent changes in gene expression patterns in fish treated with EE2. Key words: array, biomarkers, endocrine disruption, estrogen, fish, macroarray. Environ Health Perspect 111:839-846 (2003) . |
|
|
 |
Endocrine-disrupting compounds (EDCs) that mimic estrogens come from a variety
of sources, including byproducts from manufacturing, effluent from wastewater
treatment plants, and pesticides (Nimrod and Benson 1996a, 1996b; Solomon and
Schettler 2000; Sumpter 1998). Exposure to these estrogenic EDCs may lead to
a variety of physiologic problems in humans, including vaginal cancer, reproductive
tract abnormalities, cryptorchidism, semen abnormalities, and hypospadias (Carlsen
et al. 1993; Giusti et al. 1995; Giwercman et al. 1993; Sharpe and Skakkebaek
1993; Toppari 1996; Toppari et al. 1996).
A principal role of the native estrogen 17ß-estradiol (E2)
in the liver of adult female fish is to activate the synthesis of specific gene
transcripts that encode proteins required for reproduction by binding to the
estrogen receptor (ER). Several genes known to be activated by this process
include those that encode the ER itself, vitellogenins (Vtgs), and choriogenins
(Arukwe et al. 2001; Bowman et al. 2000; Celius et al. 2000; Denslow et al.
2001a, 2001b; Flouriot et al. 1995, 1996, 1997; Folmar et al. 2000; Funkenstein
et al. 2000; Hemmer et al. 2001; Lattier et al. 2001; Le Guellec et al. 1988;
Lim et al. 1991; Murata et al. 1997). Vtgs, the egg yolk precursor proteins,
and choriogenins, which are required for making the inner covering of the egg,
normally increase in the circulation of females during oogenesis (Mommsen and
Walsh 1988; Oppen-Berntsen et al. 1992; Specker and Sullivan 1994; Tyler and
Sumpter 1996). However, in males, the normal endogenous levels of E2
are sufficient to induce only very small amounts of plasma Vtgs and choriogenins
(Arukwe et al. 2001; Copeland et al. 1986). When males are exposed to natural
or anthropogenic estrogens, which can either enhance the steady-state concentrations
of endogenous E2 or bind directly to the ER, the result is an increase
in the circulating levels of Vtg and choriogenin proteins. Vtg and choriogenin
synthesis in male fish have therefore become accepted assays for measuring exposure
to estrogenic chemicals (Arukwe et al. 1997; Bevans et al. 1996; Celius et al.
1999; Celius and Walther 1998; Denslow et al. 1996; Folmar et al. 1996, 2000;
Hemmer et al. 2001; Heppell et al. 1996; Jobling et al. 1995; Orlando et al.
1999; Sumpter and Jobling 1995).
A number of natural and synthetic chemicals in the environment are estrogenic
in in vitro and in vivo assays, including 17 -ethinyl
estradiol (EE2), diethylstilbestrol (DES), p-nonylphenol (PNP),
methoxychlor (MXC), and endosulfan (ES) (Bowman et al. 2000; Bulger et al. 1978;
Coldham et al. 1997; Denslow et al. 2001a, 2001b; Folmar et al. 2000; Hemmer
et al. 2001; Larkin et al. in press; Nimrod and Benson 1997; Petit et al. 1997;
Schlenk et al. 1998; Shelby et al. 1996; Soto et al. 1995; Vonier et al. 1996).
EE2 is currently used in oral contraceptives, and DES was once prescribed
to prevent spontaneous abortion in early pregnancy (Herbst et al. 1971). PNP
is the primary microbial degradation product of alkylphenol ethoxylates (Naylor
et al. 1992), which are used as surfactants and emulsifiers in numerous industrial
and commercial applications (Nimrod and Benson 1996a, 1996b). MXC and ES, which
are both organochlorine pesticides, are used to control a variety of insects
on food crops (Solomon and Schettler 2000).
There is emerging evidence that some estrogenic compounds may have additional
modes of action independent of the ER. PNP, for example, enhances pregnane-X
receptor-mediated transcription in COS-7 cells (Masuyama et al. 2000). Pregnane
X is a nuclear receptor that regulates the expression of several genes, including
cytochrome P450 3A (Bertilsson et al. 1998; Kliewer et al. 1998; Lehmann et
al. 1998; Masuyama et al. 2000; Pascussi et al. 1999). Moreover, MXC induces
gene expression in mice via a signaling pathway that does not involve ER or
ERß (Ghosh et al. 1999; Waters et al. 2001). These studies suggest some
genes may be differentially regulated by various estrogenic compounds and raises
the possibility of specific genetic markers for some of the different EDCs that
mimic E2. Using differential display reverse transcriptase-polymerase
chain reaction (DD RT-PCR), we previously isolated 30 genes, several of
which were upregulated or downregulated in sheepshead minnows (Cyprinodon
variegatus) exposed to E2. Other genes that appeared to be constitutive
were added to the array for normalization purposes. In this study we have characterized
the expression of these genes by macroarray analysis, using RNA from livers
of male sheepshead minnows receiving an aqueous exposure to environmentally
relevant concentrations of E2, EE2, DES, PNP, MXC, or
ES.
Materials and Methods
Amplification of cDNA to Be Spotted on Macroarrays
Minipreps of 30 cDNA clones derived from DD RT-PCR analysis (Denslow
et al. 2001a, 2001b) were PCR-amplified in a 300-µL reaction containing
1 PCR Buffer
A (Promega, Madison, WI, USA), 2 mM MgCl2 (Promega), 160 µM
each deoxynucleotide triphosphate (Stratagene, La Jolla, CA, USA), 0.4 µM
M13 primers (5´-GTT TTC CCA GTC ACG ACG TTG and 5´-GCG GAT AAC AAT
TTC ACA CAG GA), and 1.25 units Taq polymerase (Promega). The PCR reaction
conditions were as follows: 1 cycle at 80°C (1 min); 1 cycle at 94°C
(2 min); 32 cycles at 94°C (1 min), 57°C (1 min), and 72°C (2
min); 1 cycle at 72°C (10 min), and then hold at 4°C. After completion
of the PCR, the products were purified in a spin column (Qiagen, Chatsworth,
CA, USA), then concentrated in a speed vacuum (Savant SVC100; Axon Instruments,
Inc., Farmingdale, NY, USA). Aliquots of the PCR products were run on a 1.2%
agarose gel containing 0.3 mM ethidium bromide. The gels were digitally imaged
using a UVP Bio Doc-It camera (Ultra-Violet Laboratory Products, Upland, CA,
USA), and the concentration of each PCR product was determined by comparing
the intensity of each band to a standard curve derived from a low DNA mass ladder
(Invitrogen Corp., Carlsbad, CA, USA). The PCR products were adjusted to a concentration
of 160 ng/µL cDNA template.
Thirty unique clones were spotted on the array. Of these, 19 were identified
based on their similarity to sequences in the National Center for Biotechnology
Information (NCBI) database as determined by the Basic Local Alignment Search
Tool (BLAST X) (Altschul et al. 1997). The highest expectation (E) value obtained
is shown in parentheses. The 30 unique genes spotted include 1-microglobulin/bikunin
precursor protein (AMBP) (E = 1e-11), ß-actin (GenBank accession no. AF253319),
choriogenin 2 (E = 1e-45), choriogenin 3 (E = 4e-43), coagulation factor XI
(E = 3e-12), ER
(E = 1e-71), glycosylate reductase (E = 3e-14), hepatic lipase precursor (E
= 7e-6), 3-hydroxy-3-methylglutaryl-coenzyme A (CoA) reductase (E = 9e-51),
low-molecular-mass protein 2 (E = 2e-12), transferrin (E = 8e-26), ubiquitin-conjugating
enzyme 9 (the cDNA clone is 87% identical at the 5´ end to an EST clone
(GenBank accession no. BJ028023) that has an E value of 1e-11 with ubiquitin-conjugating
enzyme 9), unknown protein (E = 4E-23), Vtg 1 (GenBank accession no. AF239720),
Vtg 2 (GenBank accession no. AF239721), ribosomal protein L8 (E = 7e-56), ribosomal
protein S8 (E = 5e-29), and two unique genes similar to ribosomal protein S9
(E = 2e-45 and 4e-5). The remaining 11 clones, designated NDN1-A, ND1-E, ND9C-D2,
ND10C-A, ND13C-E, ND15-B3, ND17-E3, ND96-C, ND98-E, ND102-A, and ND103-B, do
not match any sequences in the database.
Array Controls
Various controls were also spotted onto the membranes, which provided information
about cDNA labeling efficiency, blocking at the prehybridization step, and nonspecific
binding. These controls included three Arabidopsis thaliana cDNA clones,
Cot-1 repetitive sequences, poly A sequence (SpotReport 3; Stratagene), and
an M13 sequence (vector but no cDNA insert). We also assessed the consistency
of our technique by spotting on the array multiple cDNA products from the same
genes amplified in separate PCR reactions. Genes spotted multiple times on different
parts of the array include 3-hydroxy-3-methylglutaryl-CoA reductase, glycosylate
reductase, choriogenin 2, a clone that shares homology to Unknown protein (GenBank
accession no. AAH10857), and several unidentified clones (ND98-E, ND1-E, ND2C-A,
ND62-B2, and ND102-A). In all, each membrane had 62 spots in duplicate that
included the 30 unique genes described above, the multiple spotted genes, and
the procedural controls.
Spotting of the Macroarrays
The PCR products were loaded into 96-well plates (Fisher Scientific, Pittsburgh,
PA, USA), denatured with 3 M NaOH, heated to 65°C for 10 min, then immediately
quenched on ice. Twenty times saline sodium citrate (SSC) (3 M NaCl, 0.3 M sodium
citrate, pH 7.0) containing 0.01 mM bromophenol blue was added to the samples
to yield a final concentration of 0.3 M NaOH, 6
SSC, and 100 ng/µL cDNA template. The PCR products were robotically spotted
(Biomek 2000; Beckman Coulter, Fullerton, CA, USA) in duplicate onto 11.5
7.6 cm neutral nylon membranes (Fisher Scientific) using 100-nL pins. Membranes
were ultraviolet cross-linked at 1
105 µJ (UV Stratalinker 1800; Stratagene) and stored under vacuum
at room temperature until hybridization.
Sample Extraction
Total hepatic messenger ribonucleic acid (mRNA) was extracted using affinity
columns (Qiagen) from adult male sheepshead minnows treated by aqueous exposure
to either 65.14 ng/L E2, 109 ng/L EE2, 100 ng/L DES, 11.81
µg/L PNP, 590.3 ng/L ES, 5.59 µg/L MXC, or triethylene glycol (vehicle
control) using a flow-through dosing apparatus as described previously (Folmar
et al. 2000; Hemmer et al. 2001). All animals used in the research were treated
humanely according to institutional guidelines (U.S. Environmental Protection
Agency), with due consideration for the alleviation of distress and discomfort.
Three fish were used per treatment group. Criteria for selection of samples
from each compound tested were based on previously generated dose-response
curves (Folmar et al. 2000; Hemmer et al. 2001) and chosen to give similar levels
of expression of Vtg mRNA, a well-established estrogenic biomarker (Bowman et
al. 2000; Sumpter and Jobling 1995). By selecting the concentration and length
of exposure to yield similar Vtg mRNA expression levels, we accounted for differing
potencies among the chemicals tested. On the basis of this criterion, length
of exposure was 4 days for EE2 and DES, 5 days for E2
and PNP, and 13 days for MXC. ES treatment levels ranging from 68.8 ng/L to
788.33 ng/L failed to induce Vtg mRNA. We chose a treatment of 590.3 ng/L of
ES for these analyses. This level of ES was slightly below the maximum acceptable
toxicant concentration (MATC) derived for ES for sheepshead minnows (Hansen
and Cripe 1991). ES is available commercially as a mixture of two ES isomers,
and ß, which are typically supplied at the ratios of 65-70%
and 30-35% ß.
Labeling of RNA and Hybridization
Radiolabeled probes were generated by random primer labeling of DNase-treated
(DNA-free; Ambion, Inc., Austin, TX, USA) total RNA from male sheepshead minnow
livers with [ -33P]dATP
(2'-deoxyadenosine 5'-triphosphate) (Strip-EZ RT, Ambion). The blots were prehybridized
with ULTRAArray hybridization buffer (Ambion) at 64°C for 3 hr. After prehybridization,
each probe was diluted 20-fold with 10 mM disodium ethylenediaminetetraacetate,
pH 8.0, to yield 1
106 cpm incorporated 33P/mL hybridization solution. The
diluted probes were heated to 95°C for 5 min, quenched on ice for 1 min,
and added directly to the prehybridization buffer. The blots were then hybridized
overnight at 64°C. After hybridization, the blots were washed 4
15 min each with low (2
SSC, 0.5% sodium dodecyl sulfate [SDS]) and high (0.5
SSC and 0.5% SDS) stringency washes (Ambion) at 64°C.
Detection and Normalization
The membranes were exposed to a phosphor screen (Molecular Dynamics, Piscataway,
NJ, USA) at room temperature for 48 hr. The blots were quantitatively evaluated
using a Typhoon 8600 imaging system (Molecular Dynamics). For each cDNA clone
the general background of each membrane was subtracted from the average value
of the duplicate spots on the membrane. The values were normalized to the average
value of 11 cDNA clones. These genes include ribosomal proteins L8 and S8, two
unique genes similar to ribosomal protein S9, and several clones (designated
NDN1-A, ND9C-D2, ND10C-A, ND13C-E, ND17-E3, ND102-A, and D103-B) that do not
match any sequences in the NCBI database. These genes were chosen to normalize
the data because they were equally expressed in control and treated fish by
differential display analysis (data not shown) and/or they did not fluctuate
more than 1.3-fold on macro arrays from E2-treated and control fish
(Larkin et al. 2002).
Gene array data were analyzed using linear regression and 1-way analysis of
variance, with Tukey post hoc analysis (SPSS, Jandel, CA, USA).
Results
The advent of array technology has enabled researchers to analyze hundreds
to thousands of genes on a single array. As a first step toward using array
technology to assess exposure to environmental estrogens, we determined the
variability between our macroarrays. To accomplish this, aliquots of identical
RNA samples were hybridized onto two separate membranes (Figure 1A). Figure
1B illustrates a scatter plot correlating the intensity values from each spot
from the two membranes. The data points in the graph cluster along a slope of
one for all of the spots, including both the low and highly expressed cDNA clones.
Similar values were observed in four replicate experiments (mean R2
0.93, range 0.88-0.97).
|

Figure 1. Scatter plot of
a self–self-hybridization. Aliquots of identical RNA samples were
hybridized to two separate arrays shown in A. For each cDNA clone, the
general background of each membrane was subtracted from the average value
of the duplicate spots on the membrane. The values were then normalized
to the average value of 11 cDNA clones (see ”Materials and Methods”).
The data points in the graph cluster along a slope of 1 from the low to
the highly expressed cDNA clones (B), as verified by linear regression
analysis (mean R2 0.93, range 0.88–0.97) (SPSS, Jandel, CA). Ninety-five
percent confidence intervals are shown on the graph. The data on both
axes are plotted using a log10 scale.
|
cDNAs corresponding to 30 unique genes were spotted on the macroarrays. These
genes were originally isolated from DD RT-PCR experiments by comparing gene
expression profiles from control and E 2-treated fish. Hepatic mRNAs
from exposed fish were converted to cDNAs and radiolabeled. The samples were individually
hybridized to separate membranes to determine if fish treated with E 2,
EE 2, DES, PNP, MXC, and ES shared similar expression profiles. Three
separate fish were used for each treatment. Figure 2 contains representative membranes
from the different treatments; Figure 3 shows a graphic representation of the
data. Figure 3A illustrates the mean ± SEM intensity values for each of the
cDNA clones arranged in order of their expression. Figure 3B illustrates the mean
intensity values for each of the cDNA clones for E 2, EE 2,
DES, PNP, MXC, or ES divided by the mean intensity values of the respective cDNA
clones from the untreated control fish.
|

Figure 2. Macroarrays demonstrating
gene expression profiles for untreated control fish and fish exposed to
E2, EE2, DES, PNP, MXC, and ES. Three separate membranes
were used for each treatment. A representative blot is shown.
|
Several of the genes spotted on the array were upregulated or downregulated
in E2-treated fish compared with controls. The genes were identified
on the basis of the intensity values of the 11 constitutively expressed cDNA
clones used to normalize the data (see "Materials and Methods"). To identify
differentially regulated genes, the 11 reference genes were numerically ranked
with respect to each other within a treatment. The upper confidence limit was
set as the mean plus one standard deviation of the highest ranked value across
the treatment groups (mean 1.38 ± 0.28). Likewise, the lower confidence
limit was set as the mean plus one standard deviation of the lowest ranked value
across the treatment groups (mean 0.63 ± 0.21). On the basis of these criteria,
any cDNA clones in the macroarray experiments above a 1.66-fold induction were
designated as upregulated with respect to control fish, and any cDNA clones
that had a value below 0.42 were designated as downregulated. These expression
levels of 1.66 and 0.42 are similar to the 2-fold change in expression used
as cutoffs by other investigators (Coller et al. 2000; Wang et al. 2001). The
upper (1.66) and lower (0.42) confidence limits used for these experiments are
conservative, based on the observation that several genes whose expression levels
fell within these values were identified as differentially regulated by DD RT-PCR
(data not shown).
Of the 30 genes used on our array, six genes were found to be upregulated
by E2, including Vtgs 1 and 2, choriogenins 2 and 3, ER , and coagulation
factor XI. Three genes found to be downregulated by E2 were transferrin,
ß-actin, and AMBP. The remaining genes did not appear to be differentially
regulated by E2 when compared with controls. All the genes identified
as upregulated or downregulated on the arrays showed identical expression patterns
by DD RT-PCR (data not shown).
The 9 genes upregulated or downregulated by EE2, DES, PNP, and
MXC exposures showed a pattern of expression similar to that of the E2
treatment. Interestingly, a cDNA clone that shares similarity to ubiquitin-conjugating
enzyme 9 was significantly (p < 0.05) upregulated only in the PNP
treatments. Eight of the 9 genes upregulated or downregulated for E2,
EE2, DES, PNP, and MXC did not fluctuate for ES-treated fish but
instead resembled the pattern observed in control fish. The only exception was
ER , which appeared to be upregulated for all the compounds, including ES. An
additional cDNA clone that shares similarity to 3-hydroxy-3-methylglutaryl-CoA
reductase appeared to be slightly downregulated (decrease of 2.9-fold) in fish
treated with ES compared with all the other treatments and the controls.
To determine if the gene expression profiles on the array could be verified
by other techniques that monitor mRNA expression, we compared the expression
profiles of several genes on the arrays (Vtg 2, choriogenin 2, and transferrin)
to their profile by Northern blots and DD RT-PCR. Figure 4A, B shows that
both Vtg 2 and choriogenin 2 mRNA levels increase in fish treated with E2,
as measured by Northern blots and DD RT-PCR. Figure 4C illustrates that
transferrin decreases with E2 treatment. We have not quantified the
response by DD RT-PCR and Northern blot analysis compared with the arrays
because limited amounts of samples required the use of different RNA samples
in these experiments.
|
Figure 4. Comparison of Vtg
2, choriogenin 2, and transferrin expression levels by Northern blots
and by DD RT-PCR data. Northern blots and DD RT-PCR were performed
as described previously (Bowman et al. 2000; Denslow et al. 2001a).
|
To assess whether the arrays could be used as a quantitative tool to measure
the expression of multiple genes at varying concentrations of an estrogenic
chemical, we examined male sheepshead minnows exposed for 4 days to nominal
concentrations of 0, 20, 100, or 1000 ng/L EE2 (Folmar et al. 2000;
Hemmer et al. 2001). The measured concentrations were 24, 109, or
832 ng/L, respectively. Figure 5 contains representative arrays from the three
EE2 treatments. Figure 6 contains graphic illustrations of genes
whose expression levels significantly changed by more than 2-fold in one or
more of the three EE2 concentrations examined (p < 0.05).
Vtgs 1 and 2, choriogenins 2 and 3, ER , and coagulation factor XI increased
in a concentration-dependent manner in the EE2-exposed fish (Figure
6A). Three other genes, transferrin, AMBP, and ß-actin, appeared to decrease
in a dose-dependent manner (Figure 6B). These genes were the same genes that
were upregulated or downregulated in the fish exposed to E2, DES,
PNP, and MXC (Figure 3).
 |
| Figure 5. Gene expression
profiles of fish exposed to various concentrations of EE2. The
nominal concentrations were 20, 100, or 1,000 ng/L EE2, whereas
the measured concentrations were 24, 109, or 832 ng/L, respectively. Three
separate membranes were used for each treatment. Representative blots are
shown. |
 |
Figure 3. Quantification of
the E2, EE2, DES, PNP, MXC, ES, and control arrays. Rib. prot., ribosomal
protein. (A) Plot of the mean ± SEM intensity values for each of
the cDNA clones arranged in order of their expression. (B) Plot of the mean
intensity values for each of the cDNA clones for E2, EE2, DES, PNP, ES,
or MXC divided by the mean intensity values of the respective cDNA clones
for untreated control fish. The intensity values were normalized as described
in the legend of Figure 1. Any clones above the red line labeled 1.66 were
considered upregulated, any clones below the red line labeled 0.42 were
considered downregulated, and any clones between the red lines were considered
constitutive. Genes on the macroarray were designated as constitutive if
their intensity values fell within the range of the mean plus 1 standard
deviation of the highest and lowest values of the 11 clones used to normalize
the data. |
 |
Figure 6. Quantification of
the EE2 dose–response arrays. Each graph contains a plot of a gene
whose expression levels significantly increased (A) or decreased (B) more
than 2-fold at one or more of the three EE2 concentrations compared with
those of controls, as revealed by one-way analysis of variance (p < 0.05).
The data on both axes are plotted using a log10 scale. The measured concentrations
(24, 109, or 832) were used to plot the data. |
Discussion
The goal of this study was to determine the expression profile of 30 estrogen-responsive
genes in sheepshead minnows treated with both strong and weak estrogenic chemicals
in a flow-through aquatic exposure system. The 30 genes arrayed were a subset
of all genes inducible by E2. These genes were isolated by DD RT-PCR
in screening experiments where approximately 18% of RNA messages expressed in
the livers of sheepshead minnows were tested (Denslow et al. 2001a, 2001b).
In addition to genes that were upregulated and downregulated by E2,
the array also contained several constitutive genes. Although most of the genes
on the array have been identified, we are continuing to screen our sheepshead
minnow cDNA libraries to identify the remainder.
We evaluated the reproducibility of our printing process for the cDNAs by
comparing the spot intensity for each of the duplicate spots for each gene on
a membrane. The spot intensity varied on average by 6.5% between paired spots
on a single membrane. When aliquots of RNA from identical samples were evaluated
on membranes printed at the beginning, middle, and end of the printing process,
we observed similar expression patterns on all membranes (data not shown). The
interassay variability was minimal, as determined by the high R2
value (mean 0.93) observed when aliquots of the same RNA samples were hybridized
to independent membranes. Slightly more variability appeared to be associated
with the lower intensity values during the self-self hybridization test,
a condition previously observed (Richmond et al. 1999). The cDNA labeling efficiency,
blocking at the prehybridization step, and nonspecific binding also were consistent
between the different treatments, based on similar expression of the various
procedural controls present on each membrane.
Our results show similar expression patterns for the estrogen-responsive genes
on our array (Figure 3A, B). Fish exposed to E2, EE2,
DES, and MXC had identical genetic signatures for the 30 genes examined, whereas
fish exposed to PNP differed by the increased expression of one additional cDNA
clone that shares similarity to ubiquitin-conjugating enzyme 9. Six genes (Vtgs
1 and 2, choriogenins 2 and 3, ER , and coagulation factor XI) were upregulated
in sheepshead minnows exposed to E2, EE2, DES, PNP, or
MXC. The upregulation of the first 5 of the 6 identified genes was expected,
considering their involvement in the estrogen-regulated process of oogenesis.
The Vtgs, choriogenins, and ER
gene transcripts are induced by these chemicals in a variety of species (Arukwe
et al. 2001; Bowman et al. 2000; Celius et al. 2000; Denslow et al. 2001a, 2001b;
Folmar et al. 2000; Hemmer et al. 2001; Larkin et al. in press; Lattier et al.
2001). Because the ubiquitin-conjugating enzyme was not significantly upregulated
to the same levels by the natural or pharmaceutical estrogens, its regulation
may be related to another detoxification or metabolic pathway specific to alkylphenols.
Ubiquitinated proteins are targets for proteolysis and other cellular functions,
including protein trafficking and kinase activation. The different expression
pattern for PNP may be valuable when trying to identify specific estrogenic
agents in mixed effluents such as sewage treatment plant discharges.
Three genes (transferrin, ß-actin, and AMBP) were downregulated in sheepshead
minnows exposed to E2, EE2, DES, PNP, or MXC. Transferrin,
a protein involved with iron transport, is downregulated by E2 and
other estrogenic compounds in the livers of largemouth bass (Larkin et al. in
press); however, it is upregulated by E2 in livers of chickens (Lee
et al. 1978; McKnight et al. 1980). These observations suggest that transferrin
may be regulated differently across vertebrate classes. ß-Actin, a housekeeping
gene commonly used to normalize gene expression assays, was also downregulated
on our arrays for fish treated with E2, EE2, DES, PNP,
and MXC. These results suggest that ß-actin may not be a good housekeeping
gene for estrogen-responsive arrays. The AMBP gives rise to two proteins, 1-microglobulin
and bikunin. The exact function of 1-microglobulin
is unknown. However, this protein is thought to be involved in immunoregulation
(Akerstrom et al. 2000). Bikunin is the active subunit of protein/carbohydrate
complexes that together comprise the inter- -inhibitor
protein family, which plays a major role in extracellular matrix stability and
integrity (Bost et al. 1998). It is of interest to note that both ß-actin
and the precursor protein for bikunin, two proteins involved with the formation
of the cytoskeleton, were both downregulated in fish treated with estrogenic
chemicals. These data are consistent with the observations that several estrogenic
compounds disrupt cytoskeleton components in vitro (Bocca et al. 2001;
Chaudoreille et al. 1991; Sakakibara et al. 1991).
The gene expression profile of fish treated with ES did not resemble that
of the fish treated with the other test chemicals but instead resembled more
the expression pattern of the control fish. Several laboratories have shown
that micromolar (or greater) concentrations of ES can induce MCF-7 cells to
proliferate (Soto et al. 1995), interact with the trout ER (Petit et al. 1997),
and induce Vtg mRNA in trout hepatocytes (Petit et al. 1997). However, in other
studies, micromolar concentrations of ES were unable to interact with a mouse
ER to transactivate a reporter construct in HeLa cells (Shelby et al. 1996)
or compete well for binding to the mouse ER (Shelby et al. 1996). The doses
used in the above in vitro assays would be considered pharmacological
in a live animal (Hansen and Cripe 1991). Therefore, to determine whether ES
was estrogenic in a live animal, we exposed sheepshead minnows to 590.3 ng/L
ES, a concentration within the MATC of 0.58-1.2 µg/L for aquatic animals.
ES appears not to regulate (up or down) the same set of genes regulated by the
other estrogenic compounds, with the exception of ER ,
which was upregulated to a similar level in all treatment groups. This observation
suggests the cascade of events downstream of the ER in the ES-exposed fish differs
from that observed in the fish exposed to the natural and pharmaceutical estrogens
and PNP. A second cDNA clone, 3-hydroxy-3-methylglutaryl-CoA reductase,
appeared to be slightly downregulated in the ES-treated fish compared with all
the other exposure groups and controls. This gene is involved in cholesterol
and steroid biosynthesis. It will be important to confirm this downregulation
by other methods. We are developing real-time PCR assays to do this.
Although in this study we saw no differences in gene expression between estradiol
and MXC, we expect that we would see such differences in a larger array, as
it has been noted by others that in mice MXC may stimulate some genes through
pathways that do not involve ER
and ERß (Ghosh et al. 1999; Waters et al. 2001).
Additionally, we investigated the sensitivity of array technology to detect
and quantitate differences in gene expression by examining the expression profiles
of the 30 arrayed genes in sheepshead minnows exposed to environmentally relevant
(24 and 109 ng/L) and high (832 ng/L) doses of EE2. The 24-ng/L dose
represents the threshold concentration for Vtg protein induction in sheepshead
minnows (Folmar et al. 2000). Our results show that estrogen-responsive genes
vary in expression in a dose-dependent manner with increasing concentrations
of EE2 (Figures 5, 6). These genes include Vtgs 1 and 2, choriogenins
2 and 3, ER ,
coagulation factor XI, transferrin, AMBP, and ß-actin. These findings
demonstrate the potential for use of this assay in screening programs (to establish
lowest observable effect concentrations and no observed effect concentrations)
and toxicologic mode of action studies for estrogenic chemicals.
In summary, our results indicate that gene arrays have potential as screening
assays for new and existing chemicals to determine their potential estrogenic
potency. Although the array used in this study was limited in the number of
genes queried, our preliminary findings suggest EDCs that mimic estrogen will
exhibit unique genetic fingerprints, indicating the usefulness of this technology
to identify specific classes of chemicals capable of eliciting estrogenic responses
in wild populations of fish.
|
|
 |
| [References Listed in PubMed] References
Akerstrom B, Logdberg L, Berggard T, Osmark P, Lindqvist A.
2000. (1)-Microglobulin:
a yellow-brown lipocalin. Biochim Biophys Acta 1482:172-184.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller
W, et al. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 25:3389-3402.
Arukwe A, Knudsen FR, Goksoyr A. 1997. Fish zona radiata (eggshell)
protein: a sensitive biomarker for environmental estrogens. Environ Health Perspect
105:418-422.
Arukwe A, Kullman SW, Hinton DE. 2001. Differential biomarker
gene and protein expressions in nonylphenol and estradiol-17ß treated
juvenile rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol C
Toxicol Pharmacol 129:1-10.
Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L,
Sydow-Backman M, et al. 1998. Identification of a human nuclear receptor defines
a new signaling pathway for CYP3A induction. Proc Natl Acad Sci U S A 95:12208-12213.
Bevans HE, Goodbred SL, Miesner JF, Watkins SA, Gross TS, Denslow
ND, et al. 1996. Synthetic organic compounds and carp endocrinology and histology
in Las Vegas wash and Las Vegas Callville Bays of Lake Mead, Nevada, 1992 and
1995. U.S. Geological Survey, Water-Resources Invest Rep 96-4266, 12 pp.
Bocca C, Gabriel L, Miglietta A. 2001. Cytoskeleton-interacting
activity of geiparvarin, diethylstilbestrol and conjugates. Chem Biol Interact
137:285-305.
Bost F, Diarra-Mehrpour M, Martin J. 1998. Inter- -trypsin
inhibitor proteoglycan family--a group of proteins binding and stabilizing the
extracellular matrix. Eur J Biochem 252:339-346.
Bowman CJ, Kroll KJ, Hemmer MJ, Folmar LC, Denslow ND. 2000.
Estrogen-induced vitellogenin mRNA and protein in sheepshead minnow (Cyprinodon
variegatus). Gen Comp Endocrinol 120:300-313.
Bulger WH, Muccitelli RM, Kupfer D. 1978. Studies on the in
vivo estrogenic activities of methoxychlor and its metabolites. Role of
hepatic mono-oxygenase in methoxychlor activation. Biochem Pharmacol 27:2417-2423.
Carlsen E, Giwercman A, Skakkebaek NE. 1993. Declining sperm
counts and increasing incidence of testicular cancer and other gonadal disorders:
is there a connection? Ir Med J 86:85-86.
Celius T, Haugen TB, Grotmol T, Walther BT. 1999. A sensitive
zonagenetic assay for rapid in vitro assessment of estrogenic potency
of xenobiotics and mycotoxins. Environ Health Perspect 107:63-68.
Celius T, Matthews JB, Giesy JP, Zacharewski TR. 2000. Quantification
of rainbow trout (Oncorhynchus mykiss) zona radiata and vitellogenin
mRNA levels using real-time PCR after in vivo treatment with estradiol-17ß
or -zearalenol.
J Steroid Biochem Mol Biol 75:109-119.
Celius T, Walther BT. 1998. Differential sensitivity of zonagenesis
and vitellogenesis in Atlantic salmon (Salmo salar L.) to DDT pesticides.
J Exp Zool 281:346-353.
Chaudoreille MM, Peyrot V, Braguer D, Codaccioni F, Crevat
A. 1991. Qualitative study of the interaction mechanism of estrogenic drugs
with tubulin. Biochem Pharmacol 41:685-693.
Coldham NG, Dave M, Sivapathasundaram S, McDonnell DP, Connor
C, Sauer MJ. 1997. Evaluation of a recombinant yeast cell estrogen screening
assay. Environ Health Perspect 105:734-742.
Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman
RN, et al. 2000. Expression analysis with oligonucleotide microarrays reveals
that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.
Proc Natl Acad Sci U S A 97:3260-3265.
Copeland PA, Sumpter JP, Walker JP, Croft M. 1986. Vitellogenin
levels in male and female rainbow trout (Salmo gairdneri Richardson)
at various stages of the reproductive cycle. Comp Biochem Physiol 83:487-493.
Denslow ND, Bowman CJ, Ferguson RJ, Lee HS, Hemmer MJ, Folmar
LC. 2001a. Induction of gene expression in sheepshead minnows (Cyprinodon
variegatus) treated with 17ß-estradiol, diethylstilbestrol, or ethinylestradiol:
the use of mRNA fingerprints as an indicator of gene regulation. Gen Comp Endocrinol
121:250-260.
Denslow ND, Chow MM, Folmar LC, Monomelli S, Heppell SA, Sullivan
CV. 1996. Development of antibodies to teleost vitellogenins: potential biomarkers
for environmental estrogens. In: Environmental Toxicology and Risk Assessment
(Bengston DA, Henshel DS, eds). Vol ASTM STP 1306 5. Philadelphia:American Society
for Testing and Materials, 23-36.
Denslow ND, Lee HS, Bowman CJ, Hemmer MJ, Folmar LC. 2001b.
Multiple responses in gene expression in fish treated with estrogen. Comp Biochem
Physiol B Biochem Mol Biol 129:277-282.
Flouriot G, Pakdel F, Ducouret B, Ledrean Y, Valotaire Y. 1997.
Differential regulation of two genes implicated in fish reproduction: vitellogenin
and estrogen receptor genes. Mol Reprod Dev 48:317-323.
Flouriot G, Pakdel F, Ducouret B, Valotaire Y. 1995. Influence
of xenobiotics on rainbow trout liver estrogen receptor and vitellogenin gene
expression. J Mol Endocrinol 15:143-151.
Flouriot G, Pakdel F, Valotaire Y. 1996. Transcriptional and
post-transcriptional regulation of rainbow trout estrogen receptor and vitellogenin
gene expression. Mol Cell Endocrinol 124:173-183.
Folmar LC, Denslow ND, Rao V, Chow M, Crain A, Enblom J, et
al. 1996. Vitellogenin induction and reduced serum testosterone concentrations
in feral male carp (Cyprinus carpio) captured near a major metropolitan
sewage treatment plant. Environ Health Perspect 104:1096-1101.
Folmar LC, Hemmer M, Hemmer R, Bowman C, Kroll K, Denslow ND.
2000. Comparative estrogenicity of estradiol, ethinyl estradiol and diethylstilbestrol
in an in vivo, male sheepshead minnow (Cyprinodon variegatus),
vitellogenin bioassay. Aquat Toxicol 49:77-88.
Funkenstein B, Bowman C, Denslow ND, Cardinali M, Carnevali
O. 2000. Contrasting effects of estrogen on transthyretin and vitellogenin expression
in males of the marine fish, Sparus aurata. Mol Cell Endocrinol 167:33-41.
Ghosh D, Taylor JA, Green JA, Lubahn DB. 1999. Methoxychlor
stimulates estrogen-responsive messenger ribonucleic acids in mouse uterus through
a non-estrogen receptor (non-ER)
and non-ERß mechanism. Endocrinology 140:3526-3533.
Giusti RM, Iwamoto K, Hatch EE. 1995. Diethylstilbestrol revisited:
a review of the long-term health effects. Ann Intern Med 122:778-788.
Giwercman A, Carlsen E, Keiding N, Skakkebaek NE. 1993. Evidence
for increasing incidence of abnormalities of the human testis: a review. Environ
Health Perspect 101:65-71.
Hansen DJ, Cripe GM. 1991. Interlaboratory comparison of the
early life-stage toxicity test using sheepshead minnows (Cyprinodon variegatus).
In: Aquatic Toxicology and Risk Assessment (Mayes MA, Barron MG, eds). Vol 14.
Philadelphia:American Society for Testing and Materials, 354-375.
Hemmer MJ, Hemmer BL, Bowman CJ, Kroll KJ, Folmar LC, Marcovich
D, et al. 2001. Effects of p-nonylphenol, methoxychlor, and endosulfan
on vitellogenin induction and expression in sheepshead minnow (Cyprinodon
variegatus). Environ Toxicol Chem 20:336-343.
Heppell SA, Denslow ND, Folmar LC, Sullivan CV. 1996. Universal
assay of vitellogenin as a biomarker for environmental estrogens. Environ Health
Perspect 103:9-15.
Herbst AL, Ulfelder H, Poskanzer DC. 1971. Adenocarcinoma of
the vagina. Association of the maternal stilbestrol therapy with tumor appearance
in young women. N Engl J Med 284:878-881.
Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. 1995.
A variety of environmentally persistent chemicals, including some phthalate
plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587.
Kliewer A, Moore JT, Wade L, Staudinger JL, Watson MA, Jones
SA, et al. 1998. An orphan nuclear receptor activated by pregnanes defines a
novel steroid signaling pathway. Cell 92:73-82.
Larkin P, Folmar LC, Hemmer MJ, Poston AJ, Lee HS, Denslow
ND. 2002. Array technology as a tool to monitor exposure of fish to xenoestrogens.
Marine Environ Res 54:395-399.
Larkin P, Sabo-Attwood T, Kelso J, Denslow ND. In press. Gene
expression analysis of largemouth bass exposed to estradiol, nonylphenol, and
p,p´-DDE. Comp Biochem Physiol.
Lattier DL, Gordon DA, Burks DJ, Toth GP. 2001. Vitellogenin
gene transcription: a relative quantitative exposure indicator of environmental
estrogens. Environ Toxicol Chem 20:1979-1985.
Le Guellec K, Lawless K, Valotaire Y, Kress M, Tenniswood M.
1988. Vitellogenin gene expression in male rainbow trout (Salmo gairdneri).
Gen Comp Endocrinol 71:359-371.
Lee DC, McKnight GS, Palmiter RD. 1978. The action of estrogen
and progesterone on the expression of the transferrin gene. A comparison of
the response in chick liver and oviduct. J Biol Chem 253:3494-3503.
Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer
SA. 1998. The human orphan nuclear receptor PXR is activated by compounds that
regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest
102:1016-1023.
Lim EH, Ding JL, Lam TJ. 1991. Estradiol-induced vitellogenin
gene expression in a teleost fish, Oreochromis aureus. Gen Comp Endocrinol
82:206-214.
Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T, MacDonald PN.
2000. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate
pregnane X receptor-mediated transcription. Mol Endocrinol 14:421-428.
McKnight GS, Lee DC, Hemmaplardh D, Finch CA, Palmiter RD.
1980. Transferrin gene expression. Effects of nutritional iron deficiency. J
Biol Chem 255:144-147.
Mommsen TP, Walsh PJ. 1988. Vitellogenesis and oocyte assembly.
In: Fish Physiology (Hoar WS, Randall DJ, eds). New York:Academic Press, 347-406.
Murata K, Sugiyama H, Yasumasu S, Iuchi I, Yasumasu I, Yamagami
K. 1997. Cloning of cDNA and estrogen-induced hepatic gene expression for choriogenin
H, a precursor protein of the fish egg envelope (chorion). Proc Natl Acad Sci
U S A 94:2050-2055.
Naylor CG, Mieure JP, Adams WJ, Weeks JA, Castaldi FJ, Ogle
LD, et al. 1992. Alkylphenol ethoxylates in the environment. J Am Oil Chem Soc
69:695-703.
Nimrod AC, Benson WH. 1996a. Environmental effects of alkylphenol
ethoxylates. Crit Rev Toxicol 26:335-364.
------. 1996b. Estrogenic responses to xenobiotics in channel
catfish (Ictalurus punctatus). Marine Environ Res 42:155-160.
------. 1997. Xenobiotic interaction with and alteration of
channel catfish estrogen receptor. Toxicol Appl Pharmacol 147:381-390.
Oppen-Berntsen DO, Hyllner SJ, Haux C, Helvik JV, Walther BT.
1992. Eggshell zona radiata-proteins from cod (Gadus morhua): extra-ovarian
origin and induction by estradiol-17ß. Int J Dev Biol 36:247-254.
Orlando EF, Denslow ND, Folmar LC, Guillette LJ. 1999. A comparison
of the reproductive physiology of largemouth bass, Micropterus salmoides,
collected from the Escambia and Blackwater Rivers in Florida. Environ Health
Perspect 107:199-204.
Pascussi JM, Jounaidi Y, Drocourt L, Domergue J, Balabaud C,
Maurel P, et al. 1999. Evidence for the presence of a functional pregnane X
receptor response element in the CYP3A7 promoter gene. Biochem Biophys
Res Commun 260:377-381.
Petit F, Le Goff P, Cravedi JP, Valotaire Y, Pakdel F. 1997.
Two complementary bioassays for screening the estrogenic potency of xenobiotics:
recombinant yeast for trout estrogen receptor and trout hepatocyte cultures.
J Mol Endocrinol 19:321-335.
Richmond CS, Glasner, JD, Mau R, Jin H, Blattner FR. 1999.
Genome-wide expression profiling in Escherichia coli K-12. Nucleic Acids
Res 27:3821-3835.
Sakakibara Y, Saito I, Ichinoseki K, Oda T, Kaneko M, Saito
H, et al. 1991. Effects of diethylstilbestrol and its methyl ethers on aneuploidy
induction and microtubule distribution in Chinese hamster V79 cells. Mutat Res
263:269-276.
Schlenk D, Stresser DM, Rimoldi J, Arcand L, McCants J, Nimrod
AC, et al. 1998. Biotransformation and estrogenic activity of methoxychlor and
its metabolites in channel catfish (Ictalurus punctatus). Mar Environ
Res 46:159-162.
Sharpe RM, Skakkebaek NE. 1993. Are oestrogens involved in
falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395.
Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. 1996. Assessing
environmental chemicals for estrogenicity using a combination of in vitro
and in vivo assays. Environ Health Perspect 104:1296-1300.
Solomon GM, Schettler T. 2000. Environment and health. 6: Endocrine
disruption and potential human health implications. CMAJ 163:1471-1476.
Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano
FO. 1995. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic
environmental pollutants. Environ Health Perspect 103:113-122.
Specker JL, Sullivan CV. 1994. Vitellogenesis in fishes; status
and perspectives. In: Perspectives in Comparative Endocrinology (Davey KG, Peter
RE, Tobe SS, eds). Ottawa:National Research Council of Canada, 304-315.
Sumpter J. 1998. Xenoendocrine disrupters--environmental impacts.
Toxicol Lett 102-103:337-342.
Sumpter JP, Jobling S. 1995. Vitellogenesis as a biomarker
of estrogenic contamination of the aquatic environment. Environ Health Perspect
103:173-178.
Toppari J. 1996. Is semen quality declining? Andrologia 28:307-308.
Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean
P, Guillette LJ, et al. 1996. Male reproductive health and environmental xenoestrogens.
Environ Health Perspect 105:163-163.
Tyler CR, Sumpter JP. 1996. Oocyte growth and development in
teleosts. Rev Fish Biol Fisher 6:287-318.
Vonier PM, Crain DA, McLachlan JA, Guillette LJ, Arnold SF.
1996. Interaction of environmental chemicals with the estrogen and progesterone
receptors from the oviduct of the American alligator. Environ Health Perspect
12:1318-1322.
Wang W, Yang L, Suwa T, Casson PR, Hornsby PJ. 2001. Differentially
expressed genes in zona reticularis cells of the human adrenal cortex. Mol Cell
Endocrinol 173:127-134.
Waters KM, Safe S, Gaido KW. 2001. Differential gene expression
in response to methoxychlor and estradiol through ER ,
ERß, and AR in reproductive tissues of female mice. Toxicol Sci 63:47-56.
Last Updated: May 7, 2003 |
|
 |
|
| |